ABSTRACT Treatment of transformable pneumococci with DNA-intercalating agents shortly after the uptake of DNA molecules inhibited the appearance of genetic transformants. The same drug treatments applied 20 min after DNA uptake were ineffective. Ethidium bromide, proflavin, daunomycin, actinomycin D, and platinum red were found to be effective inhibitors. Donor DNA molecules reisolated from the drugtreated bacteria appeared to be associated with the resident DNA in an abnormal manner, and they had only poor transforming activity. Several stages in the extracellular part of genetic transformation have been recognized by the use of mutants (1), inhibitors (2), and physiological manipulations (3, 4). In this communication we describe an attempt to extend these studies to the identification of steps in the intracellular processing of donor DNA by the use of DNA-intercalating agents. Our studies were prompted by a recent report describing the effect of ethidium bromide on an in vitro process that may be analogous to a step in genetic recombination (5).
Inhibition of genetic transformation by DNAintercalating agents
The general design of the experiments is outlined in Fig. 1 . Brief (20 min) treatment of the recipient bacteria after DNA uptake with ethidium bromide, proflavin, or daunomycin inhibited the emergence of over 90% of the potential transformants ("early drug" of Table 1 ). An identical dose of the drugs applied with a delay, i.e., at 20 min past the time of DNase addition, had only a minor effect on the yield of transformants ("late drug").
The striking decrease in the frequency of genetic transformation was not due to some physiological defect in the recipient cells, but rather, it was caused by an inhibition of the formation of biologically active recombinant molecules, since only relatively little donor-type transforming activity could be recovered from the lysates of "early drug" treated bacteria ( Table 2) .
Recovery of resident marker activity was not affected by the drug treatments (not documented).
Recovery of donor activity was not improved by "annealing" (at 650 for 150 min) the lysates of the drug-treated recipient bacteria. Heating of the lysates (at 980 for 10 min) followed by annealing did not increase the donor activity either ( Table  2) .
Fate of isotope-labeled donor DNA molecules in recipients treated with DNA-intercalating agents Analysis by Cesium Chloride Gradients. The data in Fig.  2 may be summarized as follows: (i) over 80% of the molecules reisolated from the "early" ethidium bromide-treated cells' lysate behaved as double-stranded DNA (see also column D of Table 3 ). (if) In the lysates of control bacteria, 97% of the donor DNA was double-stranded, while (iii) recipients arrested by chilling ("cold arrest") yielded about 37% of the donor molecules in double-stranded and 63% in single-stranded form (see column G of Table 3 ). (iv) About 79% of the donor DNA reisolated from "early" ethidium bromide-treated cells sedimented with the resident DNA in neutral sucrose gradients (not documented).
Analysis by Alkaline Sucrose Gradients yielded a different picture (Fig. 3) . (i) About 56% of the donor molecules reisolated from "early" ethidium bromide-treated cells have remained associated with resident type DNA, while about 44% sedimented as donor-type single strands in the alkaline gradient. (if) Over 93% of the donor molecules reisolated from control cells remained associated with resident DNA. (ito) Most of the donor molecules (82%) from the "cold arrested" recipients sedimented as donor single strands.
Analysis of donor DNA reisolated from cells treated with daunomycin, proflavin, actinomycin D, and platinum red yielded basically similar results to the ones described for ethidium bromide treatment.
DISCUSSION
The DNA-intercalating agents, ethidium bromide, daunomycin, actinomycin D, proflavin, and platinum red, inhibit the formation of biologically active recombinant molecules. Our interpretation of the observations described in this paper is outlined in Fig. 4. [The main features of this scheme have been adopted from published models on recombinational events in genetic transformation (8) (9) (10) (11) (12) .] Donor DNA molecules arrive to the inside of the pneumococcal cells as single strands (8) and proceed via the normal route of genetic transformation to establish physical association with the resident chromosome; at least some of this association leads to the formation of covalent bonds. However, the extensive base-pairing required for complete integration is prevented by the drug molecules intercalated between neighboring base pairs in the DNA (13, 14) and the donor single strands are forced to "loop out." Such The design of the experiment (see also Fig. 1 ) was as follows: Initial exposure of the cells to DNA: Recipient competent cells were concentrated 20-fold in C medium (6) containing 0.8 mg/ml of albumin and preincubated for 2.5 min at 300 (1.4 x 109 cells per ml). The nucleasedeficient strain (endi -, exo2-) was used as recipient. Donor DNA was added to give a concentration of 10 Ag/ml. After incubation for 5 min at 300, DNA binding and the uptake reaction were terminated with pancreatic deoxyribonuclease I (Worthington) at 5-10 sg/ml, 30°, for 30 sec.
Treatment during interaction between donor DNA and resident DNA: Immediately after DNase action (at 300 for 30 sec), 1-ml portions were diluted 10-fold in chilled medium ("cold arrest"), in warmed (370) medium ("normal control"), and in warmed media containing various drugs ("early drug"). The latter samples were incubated at 370 for 20 min. Some samples were incubated at 370 for 20 min with no drug (like "normal control"); they then received drugs and were incubated for a further 20 min ("late drug"). Inhibition of bacterial growth by DNAintercalating agents was determined in preliminary experiments. The minimal concentrations that have caused immediate and at least 90% inhibition of growth were chosen for the experiments in genetic transformation. The inhibition of growth by the intercalating agents was reversible, at least in the case of relatively short treatments (up to 30 min).
Assay for potential transformants: After drug treatment 0.1-ml portions of each culture were diluted 100-fold into fresh warmed growth media. The diluted cultures were incubated at 37°. Growth was monitored by nephelometry. In some experiments the drug-treated bacteria exhibited a lag (up to a maximum of 50 min) before resuming growth. To avoid uncertainty as to the time needed for the expression of the transformed trait, all cultures were grown to equal cell density ( (5 jg/ml; specific activity, 2.1 X 106 cpm/ug), treated with pancreatic DNase, and returned to growth media at 00 ("cold arrest") or at 37°("normal control"); an additional culture at 370 also received 5 jg/ml of ethidium bromide ("early drug") as described in the legend to Table 1 . After incubation for 20 min, DNA was extracted from samples of bacteria as below.
DNA extraction: Ten milliliters of recipient cells (1.4 X 109 cells) were washed three times with 0.15 M NaCl-0.1 M sodium citrate-0.001 M EDTA (pH 7.6) and resuspended in 0.2 ml of 0.15 M NaCl-0.1 M sodium citrate-0.001 M EDTA (pH 7.6) containing 0.1% sodium deoxycholate and 0.01% of sodium dodecyl sulfate. Lysis was performed at 37°for 5 min. These lysates were diluted 10-fold with 0.15 M NaCl, deproteinized by shaking with chloroform (twice), and dialyzed. The repeated chloroform treatment removed the ethidium bromide (recognized by its red color) from the preparations. The samples in CsCl solution (2) Experimental design was identical to the one described in the legend to Table 1 , except that at various intervals after termination of DNA uptake (by DNase), DNA was extracted from samples of bacteria and assayed for ability to transform a new recipient strain with respect to original donor marker. In parallel cultures, the bacteria were treated with ethidium bromide (5 ,g/ml) and other drugs for 20 min either immediately after DNase treatment ("early drug") or after a prior incubation at 370 for 20 min without any inhibitor ("late drug"). DNA was extracted by the procedure described in the legend to Fig. 2 . One milliliter of DNA extract was derived from 7 x 107 cells. The biological activity of DNA extracts was assayed by a second round of transformation, in the following manner: competent nuclease-deficient cells (5 x 107 viable cells per ml) were diluted 5-fold with fresh C medium (6) and treated with the DNA extracts at a dilution of 1:20. After 30 min at 300, pancreatic DNase was added and the culture was incubated at 37°for 90 min. Appropriately diluted samples were plated in selective agar plates. Transformants were scored after 40 hr at 370. The extracted DNA samples were assayed for donor marker activities in two ways: directly ("without annealing") and after annealing at 650 ("with annealing").
Annealing procedure: DNA extracts were annealed by heating at 650 for 150 min with admixed single-stranded helper DNA. As helper DNA, purified wild-type DNA was heat-denatured (1000, 10 min and rapid cool) and added at a concentration of 20 yg/ml. Platinum red may not be taken up well by the bacteria since it did not cause significant growth inhibition. A combination of platinum red with triclosan (2,4'-trichloro-2'-hydroxydiphenyl ether) improved substantially the effectiveness of platinum red. Triclosan causes increased general cellular permeability (23) , and this effect may be the basis of the synergism observed.
of single-stranded DNA fragments to homologous supercoiled DNA, and it has been suggested that this process may be anal- 
